The day-to-day running of the organisation and our licensing and inspection operations are managed by a small core team, which is split into four directorates and led by a Chief Executive.
Allan Marriott-Smith became Chief Executive of the HTA in July 2015. Allan joined the HTA in May 2009, most recently working as Director of Strategy and Quality where he had corporate responsibility for the strategic and business planning process, quality improvement and the regulation of living donation. Prior to that Allan had worked for a number of years as a government statistician at the UK Statistics Authority.
As the Chief Executive of the HTA, Allan is the Accounting Officer and is responsible for implementing the strategic plan of the organisation. This involves improving the efficiency and effectiveness of regulation, ensuring that the HTA has appropriate and productive relationships with its stakeholders, and leading and managing the skilled and dedicated workforce at the HTA. Allan is also responsible for ensuring that the HTA is governed effectively and provides good value for money.
Sarah joined the HTA in October 2011 as Director of Regulation.
Sarah leads the Regulation Directorate managing our licensing processes and overseeing inspections across all sectors. She leads the development of new policies and procedures including the implementation of the European Directive on the Quality and Safety of Organs Intended for Transplant.
Sarah has spent most of her career in regulation. She has worked at the Nursing and Midwifery Council and the General Medical Council managing governance processes, leading fitness to practise investigations and delivering service improvements.
If you would like to speak to an HTA representative please contact our press office.
Vicky spent five years at the HTA between 2009 and 2014 initially working on the assessment of living organ donations and corporate policy, and latterly having operational responsibility for strategy and planning, as well as leading on the code of practice on deemed consent in Wales. Following an 18 month period at the Financial Conduct Authority working on strategy and prioritisation development, Vicky returned to the HTA in February 2016 as Director of Policy, Strategy and Communications. Vicky’s early career was spent in consumer advocacy and representation.
At the HTA Vicky is responsible for leading on both corporate and regulatory policy, supporting the Authority in their day-to-day work as well as longer-term strategic planning, and the organisation’s business plan. She also ensures our communications are timely and accessible and that we develop and build on the relationships we have with our stakeholders to deliver quality outcomes for both the public and professionals.
The professional Members of our Board come from medical and scientific backgrounds linked to our work, and the lay Members bring a wide range of business, commercial and public sector experience.
The work of the Board is varied and includes:
- Setting the strategic direction of the HTA;
- Monitoring progress against strategic objectives;
- Making decisions on policy issues of strategic importance;
- Challenging, scrutinising and monitoring the performance of the Senior Management Team;
- Approving and monitoring the communications strategy;
- Ensuring that the views of stakeholders are properly accounted for in decision making;
- Ensuring that resources are adequate to deliver the strategy and are used efficiently and effectively;
- Overseeing the remuneration arrangements for the Senior Management Team and staff;
- Participating in Audit Committee, Remuneration Committee and Members’ groups;
- Acting as a panel Member for certain decisions on living organ donation
Sharmila has been Chair of the Human Tissue Authority since April 2014. She also holds a part-time post as Director of External Affairs for the Medical Research Council.
Sharmila was previously Chief Executive of the Association of Medical Research Charities (AMRC) after a varied career spanning business, media, technology and health. She spent 12 years at the BBC latterly as Chief Operating Officer of BBC Future Media and Technology, managing the business functions of bbc.co.uk including the launch of the iPlayer. She also served for two years as Executive Director of Finance and Performance for NHS Sussex.
Sharmila has held non-executive roles in a broad range of sectors including deputy chair of the Human Fertilisation and Embryology Authority, the body that regulates all embryo research and licences assisted reproduction clinics in the UK and six years as a Charity Commissioner. In addition to her non-executive work, she was a World Fellow at Yale University in 2007/08 where she lectured on both media policy and practical cases in medical ethics.
Sharmila is currently Board Member of the BMJ, the Pension Protection Fund, and the General Council of University of Sussex, as well as an Independent Trustee-director of LifeSight, an innovative pensions Master Trust.
Amanda is chair of both the University College London Hospitals (UCLH) Organ Donation Committee and the UCL/UCLH Biobank Ethical Review Committee, having been a governor of UCLH NHS Foundation Trust from 2004 – 2011. She has been a member of the UK Donation Ethics Committee since 2012 and is also a lay member of NHS Blood and Transplant’s National Organ Donation Committee and of a guideline update committee at National Institute for Health and Care Excellence. Amanda is a living organ donor, having donated a kidney to her husband in 2008. She is also a trustee of various charities and a magistrate.
A former police officer, Bill represented the Association of Chief Police Officers on several national bodies. Following that career he has held a number of public service roles. He is currently a non-legal member of the Employment Tribunals for the Wales region and a Non-Executive Director of the Natural Resources and the Economy, Science and Transport Corporate Governance Committees within the Welsh Government.
Since 2007 Lorna has been the Medical and Research Director for NHS Blood and Transplant (NHSBT). She is due to retire from this post at the end of May 2016. Prior to that, she spent 16 years as an academic consultant with the University of Cambridge/National Blood Service. She was a founder of the UK haemovigilance scheme SHOT and the NHSBT/MRC Clinical Studies Unit.
Her interests are in clinical trials and policy making on safety issues. Lorna chaired the Royal College of Pathologists’ Transfusion Medicine Committee from 2010-2014 and now serves as the College’s Director of Publishing and Engagement. She is a Fellow Commoner of Lucy Cavendish College, University of Cambridge.
Stuart is Head of Global Clinical Development and Medical Affairs at UCB. He is a fully GMC registered physician, who trained in General Medicine and General Practice before gaining many years experience in senior leadership roles at Roche, GlaxoSmithKline, Norgine and Takeda. He founded Vermilion Life Sciences, which aims to improve patient access to medicines, by streamlining medicines development through advisory activities, as well as offering and co-ordinating provision of pro bono development input to medical research charities.
Stuart is also a Board Trustee of the Faculty of Pharmaceutical Medicine, and has worked as an external ‘Champion' for the UK Government's Office for Life Sciences, Accelerated Access Review.
Glenn resides in Northern Ireland, and has extensive experience of senior roles in the public sector, particularly within the Health and Social Care sector. A social worker by profession, he has 34 years’ experience of working in integrated health and social care bodies at frontline and senior management levels. He has been Chief Executive of the Regulation and Quality Improvement Authority since 2009, and is also a member of the Advisory Board of the European Partnership of Supervisory Organisations. He has worked continuously at both director and Chief Executive level on the Boards of a number of health and social care arm’s-length bodies since 1996. From 2007 to 2009, he was a member of Council of the Northern Ireland Social Care Council (NISCC), and was Director of Women’s and Children’s Services in the Northern HSC Trust. He was Chief Executive of the legacy Craigavon and Banbridge Community HSC Trust from 2004-2006.
Sam is a Consultant Gynaecologist, Specialist in In-Vitro Fertilisation and Clinical Director of The Lister Fertility Clinic. He publishes and lectures regularly on many aspects of assisted conception and is particularly interested in women with reduced ovarian reserve and high follicle stimulating hormone. As well as consulting, Sam is a highly skilled gynaecological surgeon specialising in laparoscopic (keyhole) surgery and removal of fibroids (myomectomy). Sam has a keen interest in and is a leading expert on oocyte donation.
Andy is Associate Dean of Translational Research at Newcastle University. After qualification as a clinical haematologist he developed a research programme in childhood leukaemia before becoming the Director of the Northern Institute for Cancer Research. He has a long-standing interest in the use of tissues for research and is the Designated Individual for the Newcastle University HTA research licence. He has served on several national grant awarding committees and currently chairs the scientific advisory board for the Bone Cancer Research Trust and sits on the National Institute for Health Research Career Development, Senior Research and Transitional Research Fellowship panel.
Anthony is a practicing consultant renal physician at the Royal London Hospital where his special interest is in transplantation medicine. He is Professor of Renal and Transplantation Medicine at Barts and The London School of Medicine and Dentistry, Queen Mary University of London, and his research interests are mechanisms of rejection and attitudes to organ donation. Anthony is currently Dean for Education at Barts and The London School of Medicine and Dentistry. He trained in Glasgow, Oxford, London and Boston USA.
Dame Sally has recently retired as the Director of the Institute of Health and Wellbeing at the University of Glasgow. From 1984 to 1998 she was director of the Medical Research Council’s Medical Sociology Unit, and from 1998 to 2013 she was Director of the Social and Public Health Sciences Unit, funded by the Medical Research Council and the Chief Scientist Office at the Scottish Government.
She is a Fellow of the Royal Society of Edinburgh and of the Academy of Medical Sciences. She has served on numerous funding and strategic research panels. Her research has aimed to further our understanding of socioeconomic, spatial, and gender inequalities in health. Her interests also include perceptions of risk, and the understandings and use of public health research by the public, policymakers, practitioners, and the press. She is a member of the Medical Research Council (2008-2016) and the Ethics and Governance Council of UK Biobank (2016-2020)
In addition to being qualified as a barrister and solicitor in Ontario, Canada, Penney is Professor of Law at the Dickson Poon School of Law and Co-Director of the Centre of Medical Law and Ethics at King’s College London. She is a member of the UK Donation Ethics Committee and the Clinical Ethics Committee of St Christopher’s Hospice.
From 2004 to 2016, she was Vice-Chair of the King's College London Research Ethics Committee. Penney is an invited member of the Working Group on Deceased Donation of the European Platform on Ethical, Legal and Psychological Issues in Transplantation (ELPAT), and was part of a small expert group which drafted recently published European guidance on the ethical, legal and psychosocial aspects of organ donation after circulatory death (DCD).
Graham was appointed Bishop of Dudley in 2014, working across Worcestershire and Dudley. He is a biologist by background and then, having studied theology, was ordained in 1996, serving in Church of England parishes in Middlesbrough, and latterly as Rector and Lecturer of Hexham Abbey in Northumberland. Whilst there, and alongside his parish work, Bishop Graham was a Lay Member of the Governance and Access Committee of the Newcastle Biomedicine Biobank at Newcastle University, where he was involved in ethical decisions about human tissue storage.